ProCE Banner Activity

Applying Evidence to Implement New and Novel Therapy in the Management of Myelofibrosis


Download these slides from a live symposium featuring expert pharmacist perspective guidance on best practices in the management of patients with myelofibrosis, with a focus on novel treatment options for patients with JAK inhibitor failure.

Released: May 23, 2023



Justin R. Arnall

Justin R. Arnall, PharmD, BCOP

Clinical Coordinator, Hematology
Atrium Health Specialty Pharmacy Service
Charlotte, North Carolina

Victoria Nachar

Victoria Nachar, PharmD, BCOP

Clinical Pharmacist Specialist, Hematology
University of Michigan Rogel Cancer Center
Ann Arbor, Michigan

Provided by

Provided by ProCE, LLC

ProCE Banner


Supported by an educational grant from GSK.



Clinical Care Options, LLC

ProCE Banner

Hematology/Oncology Pharmacy Association (HOPA)

ProCE Banner

In partnership with Clinical Care Options, LLC and the Hematology/Oncology Pharmacy Association (HOPA)